One more thing this review digs up that the ad won't tell you, because it's the kind of detail that actually matters before you hand over health information: the brand's public pages name those three individual providers but don't publish a separate corporate or legal entity name for the medical group they operate under
Furthermore, the KDIGO 2024 guidelines cover combination therapy from the perspective of SGLT2is being first-line therapy, and long-acting GLP-1 RAs being an add-on in adults with CKD and T2D who have not achieved individualised glycaemic targets despite use of metformin and SGLT2is, or who are unable to use those medications [2]
However, these lawsuits have so far targeted insurers or third parties, not employers directly, and have mostly been unsuccessful
Long-Term Maintenance After reaching your goal weight, many patients transition to a lower maintenance dose of GLP-1 to prevent regain, continue healthy habits established during treatment, schedule periodic check-ins rather than monthly appointments, and maintain their results long-term